S100A7: from mechanism to cancer therapy

Psoriasin (S100A7) promotes stress-induced angiogenesis

(2016) J. Vegfors et al.   BRITISH JOURNAL OF DERMATOLOGY

The role of S100 proteins and their receptor RAGE in pancreatic cancer

(2015) Estelle Leclerc et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

New horizons in tumor microenvironment biology: challenges and opportunities

(2015) Fei Chen et al.   BMC Medicine

RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment

(2015) M. W. Nasser et al.   CANCER RESEARCH

S100A4 promotes liver fibrosis via activation of hepatic stellate cells

(2015) Lin Chen et al.   JOURNAL OF HEPATOLOGY

Anti-S100A4 Antibody Suppresses Metastasis Formation by Blocking Stroma Cell Invasion

(2015) Jörg Klingelhöfer et al.   NEOPLASIA

S100 to receptor for advanced glycation end-products binding assay: Looking for inhibitors

(2014) Laura Padilla et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response

(2014) S R McKeown   BRITISH JOURNAL OF RADIOLOGY

Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15

(2014) R. Wolf et al.   JOURNAL OF IMMUNOLOGY

S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer

(2014) S Dakhel et al.   Oncogenesis

From Bevacizumab to Tasquinimod

(2013) Michael T. Schweizer et al.   CANCER JOURNAL

Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties

(2013) Ingrid J. Bettum et al.   CANCER LETTERS

Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents

(2013) Gabriel Limaverde-Sousa et al.   CANCER TREATMENT REVIEWS

Targeting the PDGF signaling pathway in tumor treatment

(2013) Carl-Henrik Heldin   Cell Communication and Signaling

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

Alocasia cucullata Exhibits Strong Antitumor Effect In Vivo by Activating Antitumor Immunity

(2013) Qiuxian Peng et al.   PLoS One

Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody

(2013) Jose Luis Hernández et al.   PLoS One

Antiangiogenic Therapies: Going beyond Their Limits

(2013) L. Moserle et al.   Cancer Discovery

Functions of S100 Proteins

(2012) R. Donato et al.   CURRENT MOLECULAR MEDICINE

ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry

(2012) Anne-Vibeke Laenkholm et al.   Molecular Oncology

Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation

(2011) Emman Shubbar et al.   BREAST CANCER RESEARCH AND TREATMENT

S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways

(2011) M. W. Nasser et al.   CANCER RESEARCH

Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer

(2011) Tadaaki Yamada et al.   Journal of Thoracic Oncology

S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)

(2011) Qing'e Jin et al.   PLoS One

Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?

(2010) Susann Wolf et al.   AMINO ACIDS

S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer

(2010) N R West et al.   ONCOGENE

Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer

(2010) Satyendra Chandra Tripathi et al.   PLoS One

Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas

(2008) H Zhang et al.   THORAX